Dubai: Under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence and Chairman of the UAE Genetic Diseases Association (UAEGDA), Dubai is ready to host the IFCC World Lab 2024, a significant global conference gathering laboratory professionals and scientists worldwide, happening from May 26 to May 30. For the first time ever, the international event will take place outside of Europe and in the Middle East and Africa.
The conference, to be held at the Dubai World Trade Centre, provides a platform for the free and open exchange of information on the science and technology of clinical chemistry and laboratory medicine in the academic, clinical, and industrial settings, according to the organizers, who revealed the event’s details at a press conference hosted by the Dubai Press Club.
The 26th International Summit on Clinical Chemistry and Laboratory Medicine (IFCC World Lab 2024), the 17th Arab Union Summit for Biochemistry, the 10th Conference of the Saudi Society for Biochemistry, the 8th International Conference on Genetic Disorders 2024, and the third UAE Award for Genetic Disorder Reduction are the five events that are part of the IFFC World Lab 2024.
The UAE Genetic Diseases Association team received praise from Ahmed Al Jumairi for their efforts in planning international gatherings that further Dubai’s objectives of drawing top talent, encouraging research and development, and developing into a hub for the future of science and medicine in the area. According to him, the occasion would strengthen Dubai’s standing as a hub for knowledge-based and medical tourism.
The UAE Genetic Diseases Association is celebrating its 20th anniversary at the same time as the international conference, according to Dr. Mariam Mohammed Matar. 33,282 members of the UAE community have received services from the association during the last 20 years. She emphasized that the program’s objectives complement the UAE’s health plan and its view for the medical field going forward. A thorough scientific program covering the most recent developments in genetic and medical diagnostics for all illnesses, including rare diseases, is one of the summit’s main characteristics. It also addresses the internationally recognized requirements for the licensing and application of these developments in the field of medicine.